FF 1027T

Drug Profile

FF 1027T

Alternative Names: FF-1027T

Latest Information Update: 03 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator FUJIFILM Corporation
  • Class Antineoplastics
  • Mechanism of Action Bromodomain and extraterminal domain protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Haematological malignancies; Solid tumours

Most Recent Events

  • 26 Oct 2017 Preclinical trials in Haematological malignancies in Japan (IV), before October 2017
  • 26 Oct 2017 Preclinical trials in Haematological malignancies in Japan (PO), before October 2017
  • 26 Oct 2017 Preclinical trials in Solid tumours in Japan (unspecified route), before October 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top